Ingabe izidakamizwa zisho ukuthi izingane ezingasebenzi kahle zingelashwa ngokuphumelelayo kubantu abadala abakhathazekile? Njengoba kungenangqondo njengoba kuzwakala, kungenzeka ukuthi.
Abanye odokotela banikeza izidakamizwa ze ADD / ADHD iziguli zabo ezinezifo ezingapheliyo ( ME / CFS ) futhi bathi zibone imiphumela emihle. Sinobufakazi obukhulayo bokufakazela lokhu, kodwa ucwaningo oluningi luyadingeka.
Lezi zidakamizwa zihlukaniswa njenge-neurostimulants, okusho ukuthi zishukumisa umsebenzi wobuchopho. Zisetshenziselwa i-ADD / ADHD ngoba, ngokudabukisayo, zinomphumela wokuqeda ku-ADD / ADHD ubuchopho. Njengoba kunikezwa lokho, kwenza kube nomqondo wokuthi kuzoba usizo esimweni esichazwe ukukhathala.
I-neurostimulants ethandwa kakhulu yilezi:
- Ritalin ne- Concerta , equkethe i-methylphenidate
- I-Dexedrine, equkethe dextroamphetamine
- I-Adderall, equkethe i-amphetamine ne-dextroamphetamine
- I-Vyvanse, equkethe lisdexamfetamine
Kungani Usebenzisa Neurostimulants?
Izindlela eziqondile zale mithi aziwa (okuyizinto ezivamile ngempela ezidakamizweni ezithinta ubuchopho), kodwa bakholwa ukuthi zishintsha ukutholakala kwe-neurotransmitter- norepinephrine ne- dopamine- okucatshangwa ukuthi ihlukanisiwe kokubili i-ADD / ADHD kanye ME / CFS.
I-norepinephrine ephansi ixhunyaniswe nokulahlekelwa kokuphazamiseka nezinkinga zememori, kuyilapho ukwehluleka kwe-dopamine kuhlobene nokukhubazeka kwengqondo nokuhluleka ukugxila.
Lezi zimpawu ukuthi lezi zimo ezimbili zifana.
Esinye isifundo esincane sibonisa ukuthi, kubantu abadala, lezi zimo ezimbili zinezinye izimpawu eziningi, kufaka phakathi ukukhathala okungahlongozwayo, ubuhlungu besisundu obubanzi, nokuxilongwa kwe- fibromyalgia , okuyisimo esifana ne-ME / CFS esihlanganisa nokuhlukunyezwa kwe-norepinephrin futhi i-dopamine.
Abanye odokotela baze bacindezele ukuthi abantwana abane-ADD / ADHD bangase babe engozini yokuthuthukisa i-ME / CFS njengabantu abadala, kanti isifundo esincane sika-2013 esashicilelwe emaphepheni we- Postgraduate Medicine sisekela lokho okushiwo yi-hypothesis. Abacwaningi babheka amacala amathathu ka-ME / CFS lapho isiguli singasabele kahle ekwelapheni. Bathola ukuthi bobabili babo bahlangabezana ne-ADHD futhi baphendule ekwelapheni nge-neurostimulants. Baphetha ngokuthi i-ADHD ne-ME / CFS (futhi mhlawumbe i-fibromyalgia) kungenzeka ukuthi inezinhlelo ezivamile, nokuthi i-ADHD ingase ikwazi ukuguqula i-ME / CFS noma into efanayo.
Ucwaningo olwenziwe kuyi -American Journal of Medicine mayelana ne-methylphenidate ye-ME / CFS lubonise ukuthuthukiswa okuphawulekayo kumaphesenti angu-20 abahlanganyeli. Lokhu akulona ukugunyazwa okukhulu.
Kodwa-ke, abacwaningi abaningi bakholelwa ukuthi i-ME / CFS inamaconsi amaningana amaningi afuna ukwelashwa okuhlukile. Ingabe abantu abasabela ku-methylphenidate bamele iqembu elithile? Asisazazi okwanele ukuthi sisho noma iyiphi indlela.
Ukutadisha kokuqala kokuqala kwe-dextroamphetamine eshicilelwe ku- Psychosomatics kubonise ukuthi abayisishiyagalolunye kwabangu-10 abahlanganyeli abane-ME / CFS babenokukhathala kakhulu ngenkathi bethatha lesi sidakamizwa kuqhathaniswa ne-placebo.
Ngo-2015, isifundo siphumelele ku- Clinical and Experimental Obstetrics & Gynecology esathola ukuthi i-dextroamphetamine inenzuzo ezimweni ezehlukene ezijwayelekile kubantu besifazane kunamadoda, kufaka phakathi i-ME / CFS, i-fibromyalgia, ubuhlungu be-pelvic , ne- cystitis yangaphakathi .
Ucwaningo olwenziwa ngo-2013 ku- Psychiatry Research lucacise ukuthi i-lisdexamfetamine yayisebenza kahle kakhulu kune-placebo uma ifika ekuthuthukiseni ukusebenza kobuchopho emsebenzini eM ME / CFS. Umsebenzi oPhezulu uyisethi yamakhono engqondo okusiza ukuba wenze izinto, futhi kuvame ukuphazamiseka kule nkinga. Lesi sidakamizwa sathuthukise nobuhlungu, ukukhathala, kanye nomsebenzi womhlaba wonke.
Izwi elivela
Le mithi isivele isemakethe futhi engabizi kakhulu, okwenza kube lula kubantu ukuthola. Impendulo iwukuthi bayathwala umlutha, ngakho-ke uma ubathatha, kungase kudingeke ukuba ubone udokotela wakho njalo.
Uma unesithakazelo ekuzameni lezi zidakamizwa, khuluma nodokotela wakho. Khumbula ukuthi abanye odokotela bangase bangazimisele ukubeka lezi zidakamizwa ngaphandle kwelebula ye-ME / CFS ngokusekelwe kuphela ubufakazi esiba khona manje. Qinisekisa ukuthi ukhuluma ngobubanzi bakho obugcwele bezimpawu, ezinye izimo ongabazo, nokuthi yiziphi izidakamizwa nezithako ozithathayo.
Khumbula ukuthi ayikho imithi eyodwa esebenza kuwo wonke umuntu onama-ME / CFS nokuthi akunakwenzeka ukususa zonke izimpawu zakho.
Imithombo:
> Hlola i-JH. Izithiyo zemithi kanye nezivivinyo kanye negazi. 2015; 42 (3): 267-78. > Sympathomimetic > amines yindlela ephephile, ephumelelayo kakhulu yezinkinga eziningana zesifazane ezingapheli ezingaphenduli kahle ekwelashweni okuvamile.
> Valdizán Usón JR, Idiazábal Alecha MA. Ukubuyekezwa kochwepheshe we-neurotherapeutics. 2008 Jun; 8 (6): 917-27. Izinselele zokuxilonga nokwelashwa kwesifo esingapheliyo sokukhathala: i- role > ye-methylphenidate yokukhululwa ngokushesha.
U-Valdizán Usón JR, Idiazábal Alecha MA. Ukubuyekezwa kochwepheshe we-neurotherapeutics. 2008 Jun; 8 (6): 917-27. Izinselele zokuxilonga nokwelashwa kwesifo esingapheliyo sokukhathala: indima yokumisa ngokushesha i-methylphenidate.
I-JL encane. Ucwaningo lwe-Psychiatry. 2013 Meyi 15; 207 (1-2): 127-33. Ukusetshenziswa kwe-lisdexamfetamine dimesylate ekwelapheni ukuhluleka kokusebenza okusebenzayo kanye nesifo esingapheliyo sokukhathala: isifundo esilawulwa yi-doublebo blind.
I-JL encane. Imithi yesipiliyoni. 2013 Jan; 125 (1): 162-8. Ukhathala okungapheli syndrome: ama-3 amacala kanye nengxoxo yomlando wemvelo wokukhathazeka-ukungabi nalutho / ukugula okubangelwa ukugula.